Rare diseases
Investigational molecules
Locations
Phase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
CzechiaStudy on the Effects of Semaglutide and Dulaglutide in Adults with Multiple Sclerosis Aged 18-60 with High Disease Activity
SlovakiaStudy on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes
BelgiumEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
AustriaStudy on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes
SpainStudy on Dulaglutide for Preventing Diabetes in Patients with Metabolic Syndrome Awaiting Kidney Transplantation
SpainStudy on Dulaglutide for Preventing Diabetes in New Kidney Transplant Patients
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
